96. Crohn disease Clinical trials / Disease details


Clinical trials : 2,400 Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00040521
(ClinicalTrials.gov)
April 200227/6/2002Study Evaluating rhIL-11 in Active Crohn's DiseaseA Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Orally Administered Recombinant Human Interleukin-11 (rhIL-11) for the Treatment of Patients With Active Crohn's DiseaseCrohn Disease;Inflammatory Bowel DiseaseDrug: Recombinant Human Interleukin-11 (rhIL-11)Wyeth is now a wholly owned subsidiary of PfizerNULLCompleted16 YearsN/ABothPhase 2United States